Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03157492 · ClinicalTrials.gov registry record · NA

Aural Rehabilitation for Cochlear Implant Users Via Telerehab Technology

A NA study of Hearing Loss and Deafness, sponsored by Gallaudet University.

Completed
Registry status
NA
Development phase
20
Enrollment target
5
Study locations

NCT03157492 is a NA study of Hearing Loss and Deafness that has completed, run by Gallaudet University. The registered enrollment target is 20 participants, below the 6,121-participant average among 58 other Hearing Loss trials with a reported enrollment target (100% lower). The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03157492, a NA study of Hearing Loss and Deafness, has completed, sponsored by Gallaudet University.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
5
Study locations

Study Summary

This study evaluates the benefits of short-term training via telehealth for post-lingually deafened adult cochlear implant users. Half the participants will receive aural rehabilitation and the other half cognitive training. The hypothesis is that short-term aural rehabilitation via telerehab technology will improve outcomes for post-lingually deafened cochlear implant users

Conditions Studied

Interventions

  • BEHAVIORAL Aural Rehabilitation Group
  • BEHAVIORAL Cognitive Training Group

Study Locations (5)

District of Columbia

  • Gallaudet University - Washington D.C.

Florida

  • University of South Florida - Tampa

Maryland

  • University of Maryland - College Park

New York

  • Columbia University - New York

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2017-05-02
Est. Completion 2021-10-13
Phase NA

Sponsor

Gallaudet University

4 total trials

What the Registry Record Tells You About NCT03157492

The ClinicalTrials.gov registry entry for NCT03157492 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,121-participant average among 58 other Hearing Loss trials with a reported enrollment target (100% lower). The listed sponsor is Gallaudet University, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hearing Loss appearing as the primary indexed condition, and to 2 interventions - of which Aural Rehabilitation Group is the first listed.

NCT03157492 reports 5 study locations spanning 5 distinct geographic areas - top geographies include District of Columbia, Florida, Maryland.

Frequently Asked Questions

What is clinical trial NCT03157492 about?

NCT03157492 is a clinical study titled "Aural Rehabilitation for Cochlear Implant Users Via Telerehab Technology". This study evaluates the benefits of short-term training via telehealth for post-lingually deafened adult cochlear implant users. Half the participants will receive aural rehabilitation and the other half cognitive training. The hypothesis is that short-term aural rehabilitation via telerehab techno...

What is the current status of trial NCT03157492?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2017-05-02. Estimated completion is 2021-10-13.

What conditions does trial NCT03157492 study?

This clinical trial studies the following conditions: Hearing Loss, Deafness.

What interventions are being tested in trial NCT03157492?

The interventions under investigation include: Aural Rehabilitation Group (BEHAVIORAL), Cognitive Training Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT03157492?

This trial is sponsored by Gallaudet University, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03157492 being conducted?

This trial has 5 study locations across District of Columbia, Florida, Maryland, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hearing Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.